-
Impact of COVID-19 disease and vaccination on dermatological immune-mediated inflammatory diseases atopic dermatitis, psoriasis, and vitiligo: a Target2B! substudy
van Buchem-Post, N. F., Ouwerkerk, W., Stalman, E. W., van Dam, K. P. J., Wieske, L., Bekkenk, M. W., Wolkerstorfer, A., Spuls, P., Musters, A. H., Bosma, A. L., Hijnen, D.-J., Eftimov, F., Luiten, R. M. & T2B! immunity against SARS-CoV-2 study group, Apr 2025, In: Journal of dermatology. 52, 4, p. 624-633 10 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy
the T2B! immunity against SARS-CoV-2 study group, Schreurs, C. R. G., van der Pol, W. L., Goedee, H. S. & T2B! immunity against SARS-CoV-2 study group, Sept 2024, In: Journal of allergy and clinical immunology. 154, 3, p. 754-766.e7Research output: Contribution to journal › Article* › Academic › peer-review
-
T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination
T2B! immunity against SARS-CoV-2 study group, Verstegen, N. J. M., Hagen, R. R., Kreher, C., Kuijper, L. H., van den Dijssel, J., Ashhurst, T., Kummer, L. Y. L., Cabeza, V. P., Steenhuis, M., Duurland, M. C., de Jongh, R., van der Schoot, C. E., Konijn, V. A. L., Mul, E., Kedzierska, K., van Dam, K. P. J., Stalman, E. W., Boekel, L. & Wolbink, G. & 31 others, , 16 Aug 2024, In: Journal of Neurology, Neurosurgery and Psychiatry. 95, 9, p. 855-864 10 p., jnnp-2023-332224.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
